Esophageal Squamous Cell Carcinoma Clinical Trials in Shanghai
8 recruitingShanghai, China
Showing 1–8 of 8 trials
Recruiting
Phase 2
Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC
Esophageal Squamous Cell Carcinoma
Fudan University52 enrolled1 locationNCT07403136
Recruiting
Phase 2
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Esophageal CancerEsophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital100 enrolled2 locationsNCT05978193
Recruiting
Phase 3
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li426 enrolled5 locationsNCT05043688
Recruiting
Not Applicable
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Fudan University50 enrolled1 locationNCT06401447
Recruiting
Phase 3
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
Esophageal Squamous Cell CarcinomaOligometastatic DiseaseRadiotherapy
Fudan University354 enrolled1 locationNCT06190782
Recruiting
Phase 1Phase 2
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital50 enrolled1 locationNCT06173986
Recruiting
Not Applicable
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
Metastatic Esophageal Squamous Cell Carcinoma
Fudan University100 enrolled1 locationNCT05760391
Recruiting
Phase 2Phase 3
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III
Shanghai Zhongshan Hospital176 enrolled1 locationNCT04973306